Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for...
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for ... Chemotherapy. Chemotherapy (+/- Radiation). Within 10 weeks after surgery, patients receive at least 3 courses of an adjuvant ... Chemotherapy (+/- Radiation). Within 10 weeks after surgery, patients receive at least 3 courses of an adjuvant chemotherapy ... A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02 ...https://clinicaltrials.gov/ct2/show/results/NCT00074152
The Efficacy of Chemotherapy for Cancer By Don Benjamin
Adjuvant chemotherapy for breast cancer It is widely claimed that adjuvant chemotherapy extends survival with late-stage breast ... Adjuvant treatment of breast cancer with cytotoxic drugs is one of the lynch pins of chemotherapy and the NSABP was the key ... 1. Chemotherapy - a rationale Chemotherapy acts differently from surgery and radiotherapy. It is designed to kill off fast- ... Chemotherapy for invasive cervical cancer. Recent claims have been made that chemotherapy helps with invasive cervical cancer. ...http://whale.to/cancer/benjamin2.html
Papers with the keyword Tommy John Surgery | Read by QxMD
INTRODUCTION: Adjuvant chemotherapy improves survival after curative intent resection for localized pancreatic adenocarcinoma ( ... Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer. ... as adjuvant chemotherapy for operable node-positive breast cancer. METHODS: We randomly assigned 1491 women with axillary node- ... positive breast cancer to six cycles of treatment with either TAC or FAC as adjuvant chemotherapy after surgery. The primary ...https://www.readbyqxmd.com/keyword/23405
Adjuvant Chemotherapy Overuse Highlighted In Young Colon Cancer Patients | OncologyPRO
Overuse of adjuvant chemotherapy in colon adenocarcinoma patients aged less than 50 years does not greatly improve their ... Overuse of adjuvant chemotherapy in colon adenocarcinoma patients aged less than 50 years does not greatly improve their ... 4.22 and 3.93 times more likely than later-onset patients to receive adjuvant chemotherapy for stage I, stage II low-risk ... 5-year survival rates for overall stage II and stage II low-risk patients who received surgery plus adjuvant chemotherapy did ...http://oncologypro.esmo.org/Topics/Cancer-in-Special-Situations/Cancer-in-Young-Adults/Adjuvant-Chemotherapy-Overuse-Highlighted-In-Young-Colon-Cancer-Patients
Shiroda (capecitabine) can be used for adjuvant chemotherapy after breast cancer surgery?
... can be used for adjuvant chemotherapy after breast cancer surgery?,Patients: 5.10 underwent total resection and left breast ... which is the reason for the use of adjuvant chemotherapy in breast cancer, which is not the reason for the use of adjuvant ... it is to tell you that in the adjuvant chemotherapy of breast cancer (no postoperative recurrence before chemotherapy) in the ... That's why I personally don't think there is any evidence of support for Shiroda in adjuvant chemotherapy, which is why we ...http://www.scleritis.net/galactophore/tumour/XBZSFENVV.html
"Efficacy and Toxicity of Adjuvant Chemotherapy in Elderly Patients wit" by Farid Fata, Ayoub Mirza et al.
Adjuvant chemotherapy should be presented to elderly patients with high-risk, resected colon carcinoma. The data regarding age ... adjuvant chemotherapy. RESULTS: The 5-year disease free survival rate for patients age , or =65 years (Group A) was 70% ... Elderly patients with Stage II and Stage III colon carcinoma benefit from 5-FU-based adjuvant therapy without a significant ... Although the benefit from adjuvant chemotherapy has been established clearly in patients with Stage III colon carcinoma, the ...https://scholarlyworks.lvhn.org/medicine/726/
Institute of Cancer Research Repository - Duration of adjuvant chemotherapy; Anthracyclines, taxanes and novel agents - More...
Taxotere as Adjuvant Chemotherapy Trial) Management Group (includes John Yarnold) (2002) Duration of adjuvant chemotherapy; ... Duration of adjuvant chemotherapy; Anthracyclines, taxanes and novel agents - More or less ... Barrett-Lee, P., Ellis, P., Bliss, J., TACT (Taxotere as Adjuvant Chemotherapy Trial) Management Group (includes John Yarnold) ...http://publications.icr.ac.uk/3192/
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without...
To evaluate disease-free survival of standard adjuvant gemcitabine chemotherapy with and without erlotinib for patients with ... I. To evaluate disease-free survival of adjuvant chemotherapy followed by radiotherapy and concurrent fluoropyrimidine for ... To evaluate adverse events of adjuvant chemotherapy with or without radiation therapy and concurrent fluoropyrimidine for ... To determine whether the use of concurrent fluoropyrimidine and radiotherapy following adjuvant gemcitabine based chemotherapy ...https://clinicaltrials.gov/ct2/show/record/NCT01013649?show_desc=Y
Adjuvant Chemotherapy in Older Adults With Colon Cancer | Gotoper.com
Although the mortality risk from adjuvant chemotherapy itself is quite low, chemotherapy is associated with AEs that may ... the AEs of adjuvant chemotherapy may be less appealing to older patients. Adjuvant treatment decisions require a careful ... 40 Although 6 months of therapy is the optimal duration of adjuvant chemotherapy, there is evidence that 3 months of adjuvant ... we present the evidence for adjuvant chemotherapy in older adults, discuss helpful tools that can aid in adjuvant decision ...http://www.gotoper.com/publications/ajho/2015/2015mar/adjuvant-chemotherapy-in-older-adults-with-colon-cancer
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast...
The patient and physician must be agreeable to initiate standard chemotherapy and hormonal therapy as adjuvant therapy ... To estimate failure rates as a function of recurrence score (RS) separately in the chemotherapy (arms C, D) and no chemotherapy ... is not inferior to adjuvant chemohormonal in women whose tumors meet established clinical guidelines for adjuvant chemotherapy ... Giving hormone therapy together with more than one chemotherapy drug (combination chemotherapy) has been shown to reduce the ...https://clinicaltrials.gov/ct2/show/record/NCT00310180?show_locs=Y
ASCO, ACS, ASTRO Study Finds Increased Travel Distance Affects Whether Patients Receive Adjuvant Chemotherapy - The ASCO Post
ASCO, ACS, ASTRO Study Finds Increased Travel Distance Affects Whether Patients Receive Adjuvant Chemotherapy. By ASCO. October ... Patients who traveled 50 to 249 miles were 13% less likely to receive adjuvant chemotherapy than those whose travel distance ... Patients who had to travel 250 miles or more were nearly two-thirds less likely to receive adjuvant chemotherapy. ... Evidence-based treatment guidelines recommend the use of adjuvant chemotherapy in many cancer patients within 90 days after ...http://www.ascopost.com/issues/october-10-2015/asco-acs-astro-study-finds-increased-travel-distance-affects-whether-patients-receive-adjuvant-chemotherapy/
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or...
Patients in both arms may receive adjuvant chemotherapy at least 2 weeks prior to initiation of WBI OR at least 2 weeks after ... or after completion of WBI or PBI for patients not receiving adjuvant chemotherapy) and continuing for at least 5 years. ... beginning 3-12 weeks after completion of adjuvant chemotherapy (or before, during, ... Compare local tumor control in women with ductal carcinoma in situ or stage I or II breast cancer treated with adjuvant whole ...https://clinicaltrials.gov/ct2/show/NCT00103181?term=Breast+Cancer&lup_s=09%2F03%2F2012&lup_d=30
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation
The study is designed to investigate the effect of postoperative adjuvant chemotherapy in prevention of tumor recurrence and ... Treatment with other postoperative adjuvant chemotherapy. - Survival is less than 3 months after liver transplantation. - ...http://www.knowcancer.com/cancer-trials/NCT01125020/
Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of...
Drug: AI+chemotherapy adjuvant therapy preoperative endocrinotherapy was performed by AI for 4-6 months;surgery;pathological ... AI adjuvant therapy for 5 years after adjuvant chemotherapy ... Drug: AI adjuvant therapy Drug: AI+chemotherapy adjuvant ... On one hand, the result of tamoxifen endocrine therapy combined with adjuvant chemotherapy is superior to tamoxifen endocrine ... With plan of receiving simple endocrinotherapy and avoiding adjuvant chemotherapy. *No previous breast cancer treatment history ...https://clinicaltrials.gov/ct2/show/NCT01613560
Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic...
Ki67 and p53 expression for the outcome of adjuvant chemotherapy was evaluated. In the adjuvant chemotherapy group, the ... Gallen consensus conference recommend adjuvant chemotherapy for TNBC , although a specific regimen for such adjuvant ... adjuvant chemotherapy were less likely to die compared with those who received neoadjuvant chemotherapy or no chemotherapy. In ... The adjuvant chemotherapy was performed for 138 (73%) of 190 TNBC cases; 60 cases had an anthracyclin-based regimen and 78 a 5- ...https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3068
Adjuvant chemotherapy improves survival in early-stage ovarian cancer
... information on adjuvant chemotherapy but do not address which patients can be spared unnecessary adjuvant chemotherapy. He ... either adjuvant chemotherapy immediately after surgery for early-stage ovarian cancer or no immediate adjuvant chemotherapy. ( ... observed benefit of adjuvant chemotherapy primarily in nonoptimally staged patients suggests a benefit of adjuvant chemotherapy ... optimal staging was not associated with any survival benefit in patients who received adjuvant chemotherapy. Adjuvant ...http://www.innovations-report.com/html/reports/medicine-health/report-15734.html
Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. | The BMJ
Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. Br Med J 1980; 281 :1179 ... Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy.. Br Med J 1980; 281 doi: ...http://www.bmj.com/content/281/6249/1179
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer - Full Text View - ClinicalTrials.gov
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer. The safety and scientific validity of this study is the ... Phase I/II Study of Oral S-1 Plus f Oxaliplatin as an Adjuvant Chemotherapy After Curative Resection of Stage II-IV(M0) Gastric ... chemotherapy complete rate [ Time Frame: 6 months ]. percentage of patients who completed eight cycles of chemotherapy ... The purpose of this study is to assess the safety and efficacy of S-1 plus oxaliplatin combination chemotherapy based on the ...https://clinicaltrials.gov/ct2/show/NCT01542294
Cancer Treatment: Drugs During Adjuvant Chemotherapy May Not Work | Science 2.0
... known as adjuvant chemotherapy, may not be benefiting from these drugs. ... "Adjuvant chemotherapy is a well established, but ineffective treatment in ER+ breast cancer patients aged 40 years or less . ... Article: 'Efficacy of adjuvant chemotherapy according to hormone receptor status in young breast cancer patients', Jos A. van ... known as adjuvant chemotherapy, may not be benefiting from these drugs. This is especially true if their tumors respond to ...https://www.science20.com/news_account/cancer_treatment_drugs_during_adjuvant_chemotherapy_may_not_work
Medline ® Abstract for Reference 109 of 'Adjuvant chemotherapy for resected stage II colon cancer'
... phenotype to predict benefit from adjuvant chemotherapy of colon cancer by 5-fluorouracil and leucovorin (FL) alone or with ... CONCLUSION: Our observations indicate that MSI status and p53 expression may influence the impact of oxaliplatin on adjuvant ... A Cox proportional hazards model was specifically designed to evaluate the interaction between chemotherapy and these genetic ... while the interaction of MSI with chemotherapy could not be determined in the absence of relapse in the MSI group treated with ...http://www.uptodate.com/contents/adjuvant-chemotherapy-for-resected-stage-ii-colon-cancer/abstract/109
Medline ® Abstract for Reference 18 of 'Adjuvant chemotherapy for resected stage II colon cancer'
PURPOSE: Fluorouracil plus leucovorin (FU + LV) adjuvant chemotherapy reduced the risk of recurrence and death across all time ... Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. ... PATIENTS AND METHODS: A total of 12,233 patients enrolled to the randomized trials C-07, C-08, N0147, MOSAIC (Adjuvant ... CONCLUSIONS: These analyses support the addition of oxaliplatin to fluoropyrimidine-based adjuvant therapy in patients with ...http://www.uptodate.com/contents/adjuvant-chemotherapy-for-resected-stage-ii-colon-cancer/abstract/18
Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer.
Chemotherapy, Adjuvant. Cisplatin / adverse effects, therapeutic use. Diarrhea / chemically induced, etiology. Dose ... Ten days after radiation therapy, TP regimen was administered as adjuvant chemotherapy.. RESULTS: For the experimental and ... CONCLUSION: Concurrent chemoradiotherapy plus adjuvant chemotherapy for advanced cervical cancer can improve short-term and ... This study aimed to explore the efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on and the treatment ...http://www.biomedsearch.com/nih/Efficacy-concurrent-chemoradiotherapy-plus-adjuvant/20979696.html
Elderly Colon Cancer Patients Benefit From Adjuvant Chemotherapy | Cancer Network | The Oncology Journal
... based chemotherapy after surgery can be given safely to selected elderly patients with stage II/III colon cancer, and these ... adjuvant chemo-therapy. Data from the National Cancer Institute's. Surveillance Epidemiology, and End Results Program (SEER) ... regimens after surgery with no adjuvant chemotherapy for patients with stage. II/III colon cancer. Five studies used 5-FU plus ... Reasons for withholding adjuvant chemotherapy from elderly patients may. include coexisting conditions, fear of toxicity, ...http://www.cancernetwork.com/articles/elderly-colon-cancer-patients-benefit-adjuvant-chemotherapy
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients - Full Text View - ClinicalTrials.gov
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients. The safety and scientific validity of this study is the ... Adjuvant chemotherapy is critical for improving efficacy further. Unfortunately, the optimal adjuvant regimen is not identified ... prior adjuvant chemotherapy that did not include taxanes and S-1;. *white blood count ≥ 3,500/mm3, absolute neutrophil count ≥ ... This trial is going to evaluate the efficacy and safety of two regimens of DX and XELOX as adjuvant chemotherapy for stage IIIb ...https://clinicaltrials.gov/ct2/show/NCT01618474
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach - Full Text View - ClinicalTrials.gov
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group. Randomized trial on adjuvant ... Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S). This study has been completed. ... Open Label, Randomised, Multicenter Phase III Study of Adjuvant Chemotherapy in Radically Resected Adenocarcinoma of the ... After relapse further chemotherapy is left to the investigator's judgement. When the last patient is randomised, follow-up will ...https://clinicaltrials.gov/ct2/show/NCT01640782